
Integer Holdings (ITGR) Stock Forecast & Price Target
Integer Holdings (ITGR) Analyst Ratings
Bulls say
Integer Holdings Corp experienced a notable revenue increase of 15% in its Cardio & Vascular segment during the third quarter of 2025, contributing to an optimistic growth outlook alongside a stable gross margin forecast of approximately 27% for the coming years. With projected revenue of $1.87 billion for 2026 and expected operating cash flow rising to between $230-$240 million, Integer is well-positioned to reduce its leverage ratios while capitalizing on favorable market trends in the cardiovascular device sector. These factors, alongside anticipated contributions from its product portfolio and strong demographic support, reinforce a positive long-term outlook for the company's performance in the medical device market.
Bears say
Integer Holdings Corp has revised its revenue estimates for 4Q25E to $460 million, reflecting only a 2% year-over-year increase, which is a downgrade from previous expectations. The company has also lowered its full-year 2025 revenue guidance by $16 million and provided a concerning flat-to-lower outlook for 2026E, primarily attributed to decreased demand for key product lines. Furthermore, Integer’s anticipated sales growth rate has been adjusted to 0-4%, indicating a significant decline from historically expected growth rates, raising concerns about the company's ability to drive revenue and earnings growth in the near term.
This aggregate rating is based on analysts' research of Integer Holdings and is not a guaranteed prediction by Public.com or investment advice.
Integer Holdings (ITGR) Analyst Forecast & Price Prediction
Start investing in Integer Holdings (ITGR)
Order type
Buy in
Order amount
Est. shares
0 shares